These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39414598)

  • 1. [TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR].
    Nie XM; Dong DF; Lin JF; Wu BY; Cai G
    Zhonghua Zhong Liu Za Zhi; 2024 Oct; 46(10):968-978. PubMed ID: 39414598
    [No Abstract]   [Full Text] [Related]  

  • 2. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of TRAF4 promotes lung cancer growth and EGFR-dependent phosphorylation of ERK5.
    He S; Dong D; Lin J; Wu B; Nie X; Cai G
    FEBS Open Bio; 2022 Oct; 12(10):1747-1760. PubMed ID: 35748027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
    Whitsett TG; Cheng E; Inge L; Asrani K; Jameson NM; Hostetter G; Weiss GJ; Kingsley CB; Loftus JC; Bremner R; Tran NL; Winkles JA
    Am J Pathol; 2012 Jul; 181(1):111-20. PubMed ID: 22634180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.
    Cai G; Zhu L; Chen X; Sun K; Liu C; Sen GC; Stark GR; Qin J; Li X
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11531-11536. PubMed ID: 30352854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
    Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
    EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
    Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
    Chen T; Gao F; Feng S; Yang T; Chen M
    Oncol Rep; 2015 Jul; 34(1):461-8. PubMed ID: 25976502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway.
    Zhang K; Lin G; Nie Z; Jin S; Bing X; Li Z; Li M
    Mol Cell Biochem; 2024 Aug; 479(8):2069-2079. PubMed ID: 37566200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants.
    Mittal S; Kamath A; Joseph AM; Rajala MS
    Int J Oncol; 2020 Oct; 57(4):989-1000. PubMed ID: 32945365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
    Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.